Rein Therapeutics Inc. (RNTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Rein Therapeutics Inc.

    NASDAQ: RNTX · Real-Time Price · USD
    1.19
    0.03 (2.59%)
    At close: Oct 03, 2025, 3:59 PM
    1.19
    0.00%
    After-hours: Oct 03, 2025, 06:21 PM EDT

    Rein Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
    Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 1K n/a n/a n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 -1K n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Income
    		 -61.35M -54.49M -48.88M -6.09M -25.52K -18.47K -11.27K -3.98K -1.99K
    Interest Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 -60.58M -53.77M -48.27M -5.87M -25.22K -18.07K -10.95K -3.61K -1.79K
    Net Income
    		 -53.31M -46.5M -41M -29.24K -25.22K -18.07K -10.95K -3.61K -1.79K
    Selling & General & Admin
    		 7.61M 5.04M 2.49M 16.72K 16.32K 12.92K 9.18K 3.85K 1.89K
    Research & Development
    		 10.67M 6.38M 3.33M 12.9K 9.2K 5.64K 2.18K 209.00 187.00
    Other Expenses
    		 43.06M 43.06M 43.06M 6.06M -6 -94 -94 -82 -88
    Operating Expenses
    		 61.35M 54.49M 48.88M 6.09M 25.52K 18.47K 11.27K 3.98K 1.99K
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 61.35M 54.49M 48.88M 6.09M 25.52K 18.47K 11.27K 3.98K 1.99K
    Income Tax Expense
    		 -1.54M -1.54M -1.54M n/a n/a n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 24.19M 2.19K 21.69K 21.66K 19.91K 8.3K 4.77K 4.54K 4.54K
    Shares Outstanding (Diluted)
    		 24.19M 2.19K 21.69K 21.66K 19.91K 8.3K 4.77K 4.54K 4.54K
    EPS (Basic)
    		 -2.51K -2.51K -3.47 -3.12 -3.25 -3.19 -2.33 -0.79 -0.39
    EPS (Diluted)
    		 -2.51K -2.51K -3.47 -3.12 -3.25 -3.19 -2.33 -0.79 -0.39
    EBITDA
    		 -12.49M -5.63M -28.05K -29.5K -25.4K -18.43K -11.28K -4.03K -2.07K
    EBIT
    		 -40.58M -33.71M -28.11M -29.62K -25.52K -18.56K -11.36K -4.06K -2.08K
    Depreciation & Amortization
    		 63.94K 62.94K 63K -5.73M 127.00 135.00 76.00 24.00 12.00

    Add to Watchlist